The Prospective Collection Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

  • STATUS
    Recruiting
  • End date
    May 2, 2024
  • participants needed
    2000
  • sponsor
    Wake Forest University Health Sciences
Updated on 2 December 2021
stem cell transplantation
bone marrow transplant
cell transplantation
bone marrow procedure

Summary

To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.

Details
Condition hodgkin, Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS), hodgkin's lymphomas, Bone marrow disorder, Immunodeficiency Diseases, Lymphoproliferative Disorder, childhood ALL, non-hodgkin's lymphoma (nhl), Multiple Myeloma, leukemia, acute lymphoblastic, acute lymphoid leukaemia, Non-Hodgkin's Lymphoma, anll, Lymphoproliferative disorders, acute lymphoblastic leukemia (all), Bone Marrow Disorder, chronic lymphocytic leukemia (cll), acute lymphocytic leukemia, myelodysplastic syndromes, Acute Myelogenous Leukemia (AML), Chronic myeloid leukemia, acute myelogenous leukemia, acute myeloblastic leukemia, leukemia chronic lymphocytic, MYELODYSPLASTIC SYNDROME, multiple myeloma (mm), Chronic Lymphocytic Leukemia, myelodysplastic syndrome (mds), chronic myelogenous leukemia, Germ cell tumor, Germ Cell Tumors, Preleukemia, Acute myeloid leukemia, hodgkin's lymphoma, Lymphocytic Leukemia, Acute, hodgkin lymphomas, small lymphocytic lymphoma, hodgkins lymphoma, Chronic Myeloid Leukemia, Hodgkin's Disease, Lymphoma, Lymphocytic Leukemia, Chronic
Clinical Study IdentifierNCT01890486
SponsorWake Forest University Health Sciences
Last Modified on2 December 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Planned standard of care dose intensive therapy and either an allogeneic or
autologous bone marrow transplant

Exclusion Criteria

participation in any other treatment research protocol
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note